Baxter Operating Margin 2010-2025 | BAX
Current and historical operating margin for Baxter (BAX) over the last 10 years. The current operating profit margin for Baxter as of March 31, 2025 is 10.77%.
| Baxter Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $10.77B | $-0.04B | -0.40% |
| 2024-12-31 | $10.64B | $0.01B | 0.13% |
| 2024-09-30 | $9.54B | $0.49B | 5.18% |
| 2024-06-30 | $9.44B | $0.52B | 5.49% |
| 2024-03-31 | $9.34B | $0.69B | 7.42% |
| 2023-12-31 | $10.36B | $0.71B | 6.82% |
| 2023-09-30 | $8.97B | $-0.10B | -1.13% |
| 2023-06-30 | $9.98B | $-3.16B | -31.68% |
| 2023-03-31 | $9.86B | $-2.88B | -29.19% |
| 2022-12-31 | $10.06B | $-2.85B | -28.29% |
| 2022-09-30 | $13.79B | $-2.43B | -17.63% |
| 2022-06-30 | $13.40B | $0.96B | 7.18% |
| 2022-03-31 | $12.91B | $1.12B | 8.70% |
| 2021-12-31 | $12.15B | $1.35B | 11.11% |
| 2021-09-30 | $12.45B | $1.73B | 13.92% |
| 2021-06-30 | $12.20B | $1.69B | 13.86% |
| 2021-03-31 | $11.82B | $1.60B | 13.51% |
| 2020-12-31 | $11.67B | $1.62B | 13.84% |
| 2020-09-30 | $11.53B | $1.75B | 15.14% |
| 2020-06-30 | $11.41B | $1.78B | 15.59% |
| 2020-03-31 | $11.53B | $1.80B | 15.60% |
| 2019-12-31 | $11.36B | $1.77B | 15.60% |
| 2019-09-30 | $11.14B | $1.62B | 14.56% |
| 2019-06-30 | $11.05B | $1.50B | 13.58% |
| 2019-03-31 | $11.06B | $1.54B | 13.88% |
| 2018-12-31 | $11.10B | $1.58B | 14.27% |
| 2018-09-30 | $11.08B | $1.49B | 13.42% |
| 2018-06-30 | $11.02B | $1.40B | 12.74% |
| 2018-03-31 | $10.79B | $1.37B | 12.67% |
| 2017-12-31 | $10.58B | $1.29B | 12.17% |
| 2017-09-30 | $10.43B | $1.30B | 12.49% |
| 2017-06-30 | $10.28B | $1.19B | 11.56% |
| 2017-03-31 | $10.26B | $0.91B | 8.87% |
| 2016-12-31 | $10.16B | $0.75B | 7.33% |
| 2016-09-30 | $10.12B | $0.62B | 6.13% |
| 2016-06-30 | $10.05B | $0.53B | 5.23% |
| 2016-03-31 | $9.94B | $0.55B | 5.48% |
| 2015-12-31 | $9.97B | $0.45B | 4.50% |
| 2015-09-30 | $10.15B | $0.46B | 4.55% |
| 2015-06-30 | $10.38B | $0.59B | 5.66% |
| 2015-03-31 | $12.06B | $1.16B | 9.61% |
| 2014-12-31 | $13.50B | $1.74B | 12.88% |
| 2014-09-30 | $15.03B | $2.09B | 13.93% |
| 2014-06-30 | $16.03B | $2.53B | 15.79% |
| 2014-03-31 | $15.55B | $2.70B | 17.36% |
| 2013-12-31 | $15.15B | $2.74B | 18.11% |
| 2013-09-30 | $14.33B | $2.72B | 18.99% |
| 2013-06-30 | $14.09B | $2.84B | 20.17% |
| 2013-03-31 | $14.00B | $2.79B | 19.95% |
| 2012-12-31 | $13.94B | $2.77B | 19.88% |
| 2012-09-30 | $14.03B | $2.87B | 20.47% |
| 2012-06-30 | $14.03B | $2.84B | 20.24% |
| 2012-03-31 | $14.00B | $2.89B | 20.68% |
| 2011-12-31 | $13.89B | $2.95B | 21.20% |
| 2011-09-30 | $13.80B | $2.84B | 20.61% |
| 2011-06-30 | $13.54B | $2.88B | 21.27% |
| 2011-03-31 | $13.20B | $2.75B | 20.82% |
| 2010-12-31 | $12.84B | $2.14B | 16.63% |
| 2010-09-30 | $12.82B | $2.35B | 18.31% |
| 2010-06-30 | $12.74B | $2.30B | 18.03% |
| 2010-03-31 | $12.67B | $2.35B | 18.52% |
| 2009-12-31 | $12.56B | $2.88B | 22.90% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $16.026B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $237.070B | 28.51 |
| Boston Scientific (BSX) | United States | $155.016B | 38.81 |
| Stryker (SYK) | United States | $151.431B | 31.66 |
| EssilorLuxottica (ESLOY) | France | $128.578B | 0.00 |
| Medtronic (MDT) | Ireland | $113.826B | 16.14 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.396B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.515B | 26.54 |
| ResMed (RMD) | United States | $37.575B | 28.22 |
| GE HealthCare Technologies (GEHC) | United States | $34.776B | 16.51 |
| Agilent Technologies (A) | United States | $34.216B | 22.31 |
| Terumo (TRUMY) | Japan | $26.620B | 34.58 |
| Koninklijke Philips (PHG) | Netherlands | $23.303B | 16.35 |
| Insulet (PODD) | United States | $21.112B | 82.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.610B | 11.95 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.402B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.748B | 23.48 |
| Lantheus Holdings (LNTH) | United States | $5.495B | 13.86 |
| Prestige Consumer Healthcare (PBH) | United States | $3.969B | 17.73 |
| Perrigo (PRGO) | Ireland | $3.771B | 9.56 |
| Haemonetics (HAE) | United States | $3.667B | 16.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.393B | 28.20 |
| ICU Medical (ICUI) | United States | $3.321B | 24.49 |
| QuidelOrtho (QDEL) | United States | $2.015B | 13.86 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 42.27 |
| AtriCure (ATRC) | United States | $1.594B | 0.00 |
| Acuren (TIC) | United States | $1.327B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.269B | 12.88 |
| Green Thumb Industries (GTBIF) | United States | $1.158B | 26.05 |
| Neogen (NEOG) | United States | $1.103B | 14.11 |
| Phibro Animal Health (PAHC) | United States | $1.079B | 13.79 |
| BioLife Solutions (BLFS) | United States | $1.029B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 9.45 |
| Kestra Medical Technologies (KMTS) | United States | $0.813B | 0.00 |
| Owens & Minor (OMI) | United States | $0.728B | 6.04 |
| CeriBell (CBLL) | United States | $0.671B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.443B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Surmodics (SRDX) | United States | $0.419B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.353B | 12.98 |
| Quanterix (QTRX) | United States | $0.334B | 0.00 |
| SNDL (SNDL) | Canada | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Cerus (CERS) | United States | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 23.33 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| ZimVie (ZIMV) | United States | $0.274B | 12.46 |
| Cresco Labs (CRLBF) | United States | $0.258B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Brainsway (BWAY) | Israel | $0.245B | 64.88 |
| Aurora Cannabis (ACB) | Canada | $0.242B | 71.67 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.208B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.190B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.18 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Omeros (OMER) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.50 |
| TerrAscend (TSNDF) | Canada | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.75 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |